Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains.
Koizumi Y, Sakanashi D, Ohno T, Yamada A, Shiota A, Kato H, Hagihara M, Watanabe H, Asai N, Watarai M, Murotani K, Yamagishi Y, Suematsu H, Mikamo H. Koizumi Y, et al. Among authors: murotani k. J Microbiol Immunol Infect. 2019 Dec;52(6):966-972. doi: 10.1016/j.jmii.2019.09.007. Epub 2019 Oct 30. J Microbiol Immunol Infect. 2019. PMID: 31813733 Free article.
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data.
Ito K, Murotani K, Kubo A, Kunii E, Taniguchi H, Shindoh J, Asada K, Imaizumi K, Takahashi K, Karayama M, Okuno M, Inui N, Hataji O, Morikawa S, Hayai S, Suda T, Abe T, Tsuda T, Yamagichi T, Kimura T, Oya Y, Yoshida T, Hida T. Ito K, et al. Among authors: murotani k. Cancer Sci. 2020 Oct;111(10):3705-3713. doi: 10.1111/cas.14560. Epub 2020 Aug 5. Cancer Sci. 2020. PMID: 32639668 Free PMC article.
Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics.
Koizumi Y, Sakanashi D, Ohno T, Nakamura A, Yamada A, Shibata Y, Shiota A, Kato H, Hagihara M, Asai N, Watarai M, Murotani K, Yamagishi Y, Suematsu H, Mikamo H. Koizumi Y, et al. Among authors: murotani k. J Microbiol Immunol Infect. 2021 Dec;54(6):1028-1037. doi: 10.1016/j.jmii.2020.08.015. Epub 2020 Aug 20. J Microbiol Immunol Infect. 2021. PMID: 32893142 Free article.
A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903.
Ito K, Morise M, Wakuda K, Hataji O, Shimokawaji T, Takahashi K, Furuya N, Takeyama Y, Goto Y, Abe T, Kato T, Ozone S, Ikeda S, Kogure Y, Yokoyama T, Kimura M, Yoshioka H, Murotani K, Kondo M, Saka H. Ito K, et al. Among authors: murotani k. ESMO Open. 2021 Jun;6(3):100115. doi: 10.1016/j.esmoop.2021.100115. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984681 Free PMC article.
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model.
Azuma K, Xiang H, Tagami T, Kasajima R, Kato Y, Karakawa S, Kikuchi S, Imaizumi A, Matsuo N, Ishii H, Tokito T, Kawahara A, Murotani K, Sasada T, Miyagi Y, Hoshino T. Azuma K, et al. Among authors: murotani k. J Immunother Cancer. 2022 May;10(5):e004420. doi: 10.1136/jitc-2021-004420. J Immunother Cancer. 2022. PMID: 35569917 Free PMC article.
374 results